Guodi Liu

发表

The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice

Qian Zhang, Linsong Zhang, Juan Fu, 2021, Molecular therapy oncolytics.

Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo.

Qian Zhang, Linsong Zhang, Yong Zhang, 2021, Experimental cell research.

XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity

Jingfeng Wang, Mingchao Zhang, Lifen Xie, 2022, Journal of virology.

B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo

Qian Zhang, Linsong Zhang, Lu Wang, 2022, BMC Cancer.

Construction of CAR-T Cells Targeting TM4SF1 and its Anti-tumor Capacity in Ovarian Cancer.

L. Ouyang, Yijie Shen, Guodi Liu, 2023, Immunology letters.

PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cells.

Ying-Ru Pan, Qian Zhang, Linsong Zhang, 2020, Human immunology.

Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model

Yuhong Shang, Liao Dehua, Juan Fu, 2020, The Journal of veterinary medical science.

Detection of residual E. coli host cell DNA by 23S ribosomal RNA gene-targeted quantitative polymerase chain reactions.

Xiang Li, Qian Zhang, Linsong Zhang, 2021, Journal of pharmaceutical and biomedical analysis.

Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1

Lixin Zhang, Jiawen Ma, Guodi Liu, 2023, mAbs.